CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)	Common stock	Additional paid-capital	Accumulated deficit	Total
Balance at Dec. 31, 2020	$ 29,975	$ 262,286,008	$ (202,172,455)	$ 60,143,528
Balance (in shares) at Dec. 31, 2020	29,975,264
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock, net of issuance costs	$ 10,245	42,210,099		42,220,344
Issuance of common stock, net of issuance costs (in shares)	10,244,326
Issuance of restricted stock	$ 1,019	(1,019)
Issuance of restricted stock (in shares)	1,018,822
Exercise of stock options	$ 13	47,893		47,906
Exercise of stock options (in shares)	13,125
Stock-based compensation expense		1,264,837		1,264,837
Net loss			(7,961,628)	(7,961,628)
Balance at Mar. 31, 2021	$ 41,252	305,807,818	(210,134,083)	95,714,987
Balance (in shares) at Mar. 31, 2021	41,251,537
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation expense		1,934,349		1,934,349
Net loss			(9,950,079)	(9,950,079)
Balance at Jun. 30, 2021	$ 41,252	307,742,167	(220,084,162)	87,699,257
Balance (in shares) at Jun. 30, 2021	41,251,537
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of restricted stock	$ 30	(30)
Issuance of restricted stock (in shares)	30,000
Stock-based compensation expense		1,569,993		1,569,993
Net loss			(10,582,251)	(10,582,251)
Balance at Sep. 30, 2021	$ 41,282	309,312,130	(230,666,413)	78,686,999
Balance (in shares) at Sep. 30, 2021	41,281,537
Balance at Dec. 31, 2021	$ 41,218	310,353,595	(239,481,479)	70,913,334
Balance (in shares) at Dec. 31, 2021	41,217,537
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock, net of issuance costs	$ 857	1,582,916		1,583,773
Issuance of common stock, net of issuance costs (in shares)	857,060
Issuance of restricted stock	$ 1,249	(1,249)
Issuance of restricted stock (in shares)	1,249,500
Stock-based compensation expense		1,160,482		1,160,482
Net loss			(8,490,619)	(8,490,619)
Balance at Mar. 31, 2022	$ 43,324	313,095,744	(247,972,098)	65,166,970
Balance (in shares) at Mar. 31, 2022	43,324,097
Balance at Dec. 31, 2021	$ 41,218	310,353,595	(239,481,479)	70,913,334
Balance (in shares) at Dec. 31, 2021	41,217,537
Balance at Sep. 30, 2022	$ 47,063	319,210,944	(266,501,253)	52,756,754
Balance (in shares) at Sep. 30, 2022	47,062,711
Balance at Mar. 31, 2022	$ 43,324	313,095,744	(247,972,098)	65,166,970
Balance (in shares) at Mar. 31, 2022	43,324,097
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock, net of issuance costs	$ 489	818,877		819,366
Issuance of common stock, net of issuance costs (in shares)	488,892
Issuance of restricted stock	$ 123	(123)
Issuance of restricted stock (in shares)	123,154
Stock-based compensation expense		1,108,543		1,108,543
Net loss			(9,853,006)	(9,853,006)
Balance at Jun. 30, 2022	$ 43,936	315,023,041	(257,825,104)	57,241,873
Balance (in shares) at Jun. 30, 2022	43,936,143
Increase (Decrease) in Stockholders' Equity (Deficit)
Issuance of common stock, net of issuance costs	$ 2,780	3,147,150		3,149,930
Issuance of common stock, net of issuance costs (in shares)	2,779,346
Commitment shares issued under an equity purchase agreement	$ 347	(347)
Commitment shares issued under an equity purchase agreement (in shares)	347,222
Stock-based compensation expense		1,041,100		1,041,100
Net loss			(8,676,149)	(8,676,149)
Balance at Sep. 30, 2022	$ 47,063	$ 319,210,944	$ (266,501,253)	$ 52,756,754
Balance (in shares) at Sep. 30, 2022	47,062,711